BCL10 Antikörper
(1 reference)Kurzübersicht für BCL10 Antikörper (ABIN965650)
Target
Alle BCL10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Ni-NTA purified recombinant human BCL-10 expressed in E. Coli strain BL21 (DE3).
-
Aufreinigung
- Antibodies are purified by protein A affinity chromatography
-
Isotyp
- IgG1
-
-
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-143) antibody
BCL10 Reaktivität: Human WB, FACS, IHC (p) Wirt: Maus Monoclonal 1185CT13-2-1-2 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Maus WB, IHC, ELISA, FACS, ICC Wirt: Maus Monoclonal 4F8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyKD Validated BCL10 Reaktivität: Human WB, FACS, ICC Wirt: Kaninchen Monoclonal 23GB1410 unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 24-51), (N-Term) antibodyBCL10 Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB24271 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyKD Validated BCL10 Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 24GB2925 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 98-234) antibodyBCL10 Reaktivität: Human ELISA, FACS Wirt: Maus Monoclonal 3C11F4 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human WB, IHC, FACS, StM Wirt: Maus Monoclonal BL10-411 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 122-168) antibodyBCL10 Reaktivität: Human IHC, IF, FACS, StM Wirt: Kaninchen Monoclonal BL10-2988R unconjugated Recombinant Antibody
anti-B-Cell CLL/lymphoma 10 (BCL10) antibodyBCL10 Reaktivität: Human, Hund WB, IHC, IHC (p) Wirt: Maus Monoclonal 6A8 unconjugated
anti-B-Cell CLL/lymphoma 10 (BCL10) (AA 1-233) antibodyBCL10 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
IHC(P): Dilution 1: 100- 1: 500
IHC(F): Dilution 1: 200- 1: 1000
Western blot: Dilution 1: 2000- 1: 5000
ELISA: Propose dilution 1: 10000.
Determining optimal working dilutions by titration test. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Lagerung
- -20 °C
-
-
-
: "Vasoconstrictor responsiveness of portal hypertensive vessels." in: Clinical science (London, England : 1979), Vol. 96, Issue 1, pp. 3-4, (1999) (PubMed).
-
: "Vasoconstrictor responsiveness of portal hypertensive vessels." in: Clinical science (London, England : 1979), Vol. 96, Issue 1, pp. 3-4, (1999) (PubMed).
-
- BCL10 (B-Cell CLL/lymphoma 10 (BCL10))
-
Andere Bezeichnung
- BCL-10
-
Hintergrund
- Bcl-10 is a 31kDa protein containing a caspase recruitment domain (CARD). It plays an important role in apoptosis and activating NF-kappaB. The research suggested that it interacted with other CARD domain containing proteins including CARD9, 10, 11 and 14, which were thought to function as upstream regulators in NF-kappaB signaling. Bcl10 is found to form a complex with MALT1 which encoded by another gene known to be translocated in MALT lymphoma. MALT1 and Bcl-10 are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy.
-
Gen-ID
- 8915
-
Pathways
- T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Activation of Innate immune Response, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Positive Regulation of Endopeptidase Activity, BCR Signaling, Ubiquitin Proteasome Pathway, S100 Proteine
Target
-
